This trial aims to improve the Argus II device, which helps people with severe vision loss see by sending electrical signals to their eyes. The study focuses on patients with retinal diseases and seeks to make their vision clearer by developing better signal-sending methods. The Argus II device was developed to restore some vision to patients blind due to specific retinal conditions and has been tested for many years.